Persistence, severity and reactivity thresholds in fish allergic patients sensitized to parvalbumin.

Rosialzira Natasha Vera-Berrios, Sonia Vázquez-Cortés, Alejandro Gonzalo-Fernández, Carsten Bindslev-Jensen, Michael Clausen, Rosa Ferrara, Maria Gunnbjornsdottir, Laurian Jongejan, Anna Lewandowska-Polak, Adriano Mari, Nikolaos Papadopoulos, Lars K Poulsen, Náyade Del Prado, Sara Santos Magadán, Heidi Schnoor, George Stavroulakis, Serge A Versteeg, Marianne Witten, Ronald van Ree, Montserrat Fernández-Rivas
{"title":"Persistence, severity and reactivity thresholds in fish allergic patients sensitized to parvalbumin.","authors":"Rosialzira Natasha Vera-Berrios, Sonia Vázquez-Cortés, Alejandro Gonzalo-Fernández, Carsten Bindslev-Jensen, Michael Clausen, Rosa Ferrara, Maria Gunnbjornsdottir, Laurian Jongejan, Anna Lewandowska-Polak, Adriano Mari, Nikolaos Papadopoulos, Lars K Poulsen, Náyade Del Prado, Sara Santos Magadán, Heidi Schnoor, George Stavroulakis, Serge A Versteeg, Marianne Witten, Ronald van Ree, Montserrat Fernández-Rivas","doi":"10.1016/j.jaip.2024.12.026","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Fish allergy affects children and adults worldwide and there are transient and persistent phenotypes.</p><p><strong>Objective: </strong>We aimed to analyze persistence, severity and reactivity thresholds in challenge-confirmed fish allergic patients sensitized to parvalbumin.</p><p><strong>Methods: </strong>Patients 12-65 years-old reporting immediate reactions to fish, with fish skin prick test ≥5 mm and IgE to cod and carp β-parvalbumins ≥0.70 kU<sub>A</sub>/L were recruited in 6 European centers. Except if recent severe anaphylaxis, patients were eligible for a double-blind placebo-controlled food challenge with cod, followed, if negative, by an open food challenge. Severity of reported and elicited reactions was graded with FASS, eliciting dose (ED) was calculated using interval-censoring survival analysis and probabilistic models, and factors associated with a positive challenge and severe reactions were analyzed by logistic regression.</p><p><strong>Results: </strong>Out of 42 patients fulfilling inclusion criteria, fish allergy was confirmed in 30 (71.4%). The median fish allergy duration was 23 yr. Although 70% of cases reported anaphylaxis with respiratory or cardiovascular involvement, food challenges resulted in oropharyngeal symptoms (34.7%) or mild systemic reactions (73.9%), with only 1 anaphylaxis with bronchospasm (4.3%). Male sex was associated with severe reactions (OR 5.44, 95%CI 1.04-28.53). ED<sub>10</sub> for objective symptoms range was 0.99-2.54 mg protein. No correlation was found between severity and ED.</p><p><strong>Conclusion: </strong>Adolescents and adults with persistent fish allergy linked to parvalbumin sensitization have experienced severe allergic reactions in real life and have a low threshold of reactivity. Our findings support the need for large-scale studies and new therapeutic options for these fish allergic patients.</p>","PeriodicalId":51323,"journal":{"name":"Journal of Allergy and Clinical Immunology-In Practice","volume":" ","pages":""},"PeriodicalIF":8.2000,"publicationDate":"2024-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Allergy and Clinical Immunology-In Practice","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jaip.2024.12.026","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ALLERGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Fish allergy affects children and adults worldwide and there are transient and persistent phenotypes.

Objective: We aimed to analyze persistence, severity and reactivity thresholds in challenge-confirmed fish allergic patients sensitized to parvalbumin.

Methods: Patients 12-65 years-old reporting immediate reactions to fish, with fish skin prick test ≥5 mm and IgE to cod and carp β-parvalbumins ≥0.70 kUA/L were recruited in 6 European centers. Except if recent severe anaphylaxis, patients were eligible for a double-blind placebo-controlled food challenge with cod, followed, if negative, by an open food challenge. Severity of reported and elicited reactions was graded with FASS, eliciting dose (ED) was calculated using interval-censoring survival analysis and probabilistic models, and factors associated with a positive challenge and severe reactions were analyzed by logistic regression.

Results: Out of 42 patients fulfilling inclusion criteria, fish allergy was confirmed in 30 (71.4%). The median fish allergy duration was 23 yr. Although 70% of cases reported anaphylaxis with respiratory or cardiovascular involvement, food challenges resulted in oropharyngeal symptoms (34.7%) or mild systemic reactions (73.9%), with only 1 anaphylaxis with bronchospasm (4.3%). Male sex was associated with severe reactions (OR 5.44, 95%CI 1.04-28.53). ED10 for objective symptoms range was 0.99-2.54 mg protein. No correlation was found between severity and ED.

Conclusion: Adolescents and adults with persistent fish allergy linked to parvalbumin sensitization have experienced severe allergic reactions in real life and have a low threshold of reactivity. Our findings support the need for large-scale studies and new therapeutic options for these fish allergic patients.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
11.10
自引率
9.60%
发文量
683
审稿时长
50 days
期刊介绍: JACI: In Practice is an official publication of the American Academy of Allergy, Asthma & Immunology (AAAAI). It is a companion title to The Journal of Allergy and Clinical Immunology, and it aims to provide timely clinical papers, case reports, and management recommendations to clinical allergists and other physicians dealing with allergic and immunologic diseases in their practice. The mission of JACI: In Practice is to offer valid and impactful information that supports evidence-based clinical decisions in the diagnosis and management of asthma, allergies, immunologic conditions, and related diseases. This journal publishes articles on various conditions treated by allergist-immunologists, including food allergy, respiratory disorders (such as asthma, rhinitis, nasal polyps, sinusitis, cough, ABPA, and hypersensitivity pneumonitis), drug allergy, insect sting allergy, anaphylaxis, dermatologic disorders (such as atopic dermatitis, contact dermatitis, urticaria, angioedema, and HAE), immunodeficiency, autoinflammatory syndromes, eosinophilic disorders, and mast cell disorders. The focus of the journal is on providing cutting-edge clinical information that practitioners can use in their everyday practice or to acquire new knowledge and skills for the benefit of their patients. However, mechanistic or translational studies without immediate or near future clinical relevance, as well as animal studies, are not within the scope of the journal.
期刊最新文献
Increased Incidence of Surgical Intervention for Otitis Media With Effusion Among Patients With Type 2 Inflammatory Diseases. Hazelnut oral immunotherapy desensitizes hazelnut but not other tree nut allergies (Nut CRACKER Study). Impact of parent-reported antibiotic allergies on paediatric Antimicrobial Stewardship Programs. Impact of smoking on biological treatment response in patients from the German Severe Asthma (GAN) Registry. Relationships between Chronic Cough and Asthma Control and Quality-of-Life in Patients with Severe Asthma: A 6-Month Longitudinal Analysis.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1